Yi Andy An

ORCID: 0000-0001-9777-4456
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Research and Splicing
  • RNA modifications and cancer
  • Neonatal and Maternal Infections
  • Neonatal and fetal brain pathology
  • Parkinson's Disease Mechanisms and Treatments
  • RNA regulation and disease
  • Sepsis Diagnosis and Treatment
  • Cancer-related molecular mechanisms research
  • Genomics and Phylogenetic Studies

University of British Columbia
2018-2024

British Columbia Children's Hospital
2018

Parkinson disease (PD) is the second most common neurodegenerative disorder and leading cause of motor disability. Pathologic accumulation aggregated alpha synuclein (AS) protein in brain, imbalance nigrostriatal system due to loss dopaminergic neurons substantia nigra- pars compacta, are hallmark features PD. AS aggregation propagation considered trigger neurotoxic mechanisms PD, including mitochondrial deficits oxidative stress. The eukaryotic elongation factor-2 kinase (eEF2K) mediates...

10.1186/s40478-018-0554-9 article EN cc-by Acta Neuropathologica Communications 2018-06-29

R package pathlinkR is designed to aid transcriptomic analyses by streamlining and simplifying the process of analyzing interpreting differentially expressed genes derived from human RNA-Seq data. It provides an integrated approach performing pathway enrichment network-based analyses, while also producing publication-quality figures summarize these results, allowing users more efficiently interpret their findings extract biological meaning large amounts available install software repository...

10.1371/journal.pcbi.1012422 article EN cc-by PLoS Computational Biology 2024-09-16

Neonatal sepsis is a deadly disease with non-specific clinical signs, delaying diagnosis and treatment. There remains need for early biomarkers to facilitate timely intervention. Our objective was identify neonatal gene expression that could predict at birth, prior presentation.

10.1016/j.ebiom.2024.105411 article EN cc-by-nc-nd EBioMedicine 2024-10-01
Coming Soon ...